ResearcherUniversity of MiamiActive in the last 2 years
Beatriz Mateo-Victoriano
Matched on ORCID iD 0000-0003-3281-4933; OpenAlex author ID A5036764473; NIH RePORTER profile ID 78095047. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 14
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 grant
Papers 4
- Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance in PDAC. Co-author DOI 10.1080/19490976.2022.2096328↗
- Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-20-2562↗
- Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine. Co-author DOI 10.1097/cad.0000000000000598↗
- Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells. Co-author DOI 10.1097/cad.0000000000000390↗
Grants 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Sulagna Banerjee · 2 shared papers, 2021–2022 · strength 0.25
- Paper Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance… DOI 10.1080/19490976.2022.2096328↗
- Paper Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancre… DOI 10.1158/0008-5472.can-20-2562↗
- Kousik Kesh · 2 shared papers, 2021–2022 · strength 0.25
- Paper Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance… DOI 10.1080/19490976.2022.2096328↗
- Paper Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancre… DOI 10.1158/0008-5472.can-20-2562↗
- Vineet Kumar Gupta · 2 shared papers, 2021–2022 · strength 0.25
- Paper Obesity enriches for tumor protective microbial metabolites and treatment refractory cells to confer therapy resistance… DOI 10.1080/19490976.2022.2096328↗
- Paper Hypoxia-Driven Oncometabolite L-2HG Maintains Stemness-Differentiation Balance and Facilitates Immune Evasion in Pancre… DOI 10.1158/0008-5472.can-20-2562↗
- Joseph W. Harding · 2 shared papers, 2016–2018 · strength 0.15
- Paper Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer se… DOI 10.1097/cad.0000000000000598↗
- Paper Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibi… DOI 10.1097/cad.0000000000000390↗
- Brett R. Vanderwerff · 2 shared papers, 2016–2018 · strength 0.15
- Paper Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer se… DOI 10.1097/cad.0000000000000598↗
- Paper Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibi… DOI 10.1097/cad.0000000000000390↗
- Kevin J. Church · 2 shared papers, 2016–2018 · strength 0.15
- Paper Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer se… DOI 10.1097/cad.0000000000000598↗
- Paper Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibi… DOI 10.1097/cad.0000000000000390↗
- Roberto Méndez · 1 shared paper, 2022 · strength 0.15
- Nipun B. Merchant · 1 shared paper, 2022 · strength 0.15
- Santanu Banerjee · 1 shared paper, 2022 · strength 0.15
- Jashodeep Datta · 1 shared paper, 2022 · strength 0.15
- Sai Sundeep Kollala · 1 shared paper, 2021 · strength 0.11
- Nikita Sharma · 1 shared paper, 2021 · strength 0.11
- Pankaj Kumar Singh · 1 shared paper, 2021 · strength 0.11
- Ashok Kumar Saluja · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.